Market release | 21 August 2020 |
Arrangements for the Adjourned 2020 Annual Meeting
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) has provided a copy of its Notice of Adjourned Annual Meeting of Shareholders 2020 advising that the Annual Meeting of shareholders of AFT scheduled for 12 August 2020 will be convened and held on a fully virtual basis on Tuesday, 8 September 2020 at 10.30am (New Zealand time) to transact the business set out in the Notice of Annual Meeting of Shareholders 2020 dated 15 July 2020. A copy of the Notice of Adjourned Annual Meeting of Shareholders 2020 will be sent to shareholders.
ENDS
- Released for and on behalf of AFT Pharmaceuticals Limited by Chief Financial Officer Malcolm Tubby
For more information | |
Investors | Media |
Malcolm Tubby | Richard Inder |
CFO | The Project |
AFT Pharmaceuticals | +64 21 645 643 |
Tel: +64 9 488 0232 |
About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Our product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. Our business model is to develop and in-license products for sale by our own dedicated sales teams in our home markets of Australia and New Zealand and in certain Southeast Asian markets, and to out-license our products to local licensees and distributors to the rest of the world.
103372.1 - 1166057-1
Attachments
- Original document
- Permalink
Disclaimer
AFT Pharmaceuticals Limited published this content on 24 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 August 2020 22:03:22 UTC